BNP Paribas Financial Markets
SEEL

BNP Paribas Financial Markets’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

BNP Paribas Financial Markets’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$1 – 4261
2024
Q2 		– Hold
0
– – – 4035
2024
Q1 		– Hold
0
– – – 4023
2023
Q4 		– Hold
0
– -$13 – 4118
2023
Q3 		– Hold
0
– – – 3888
2023
Q2 		– Hold
0
– – – 3864
2023
Q1 		– Hold
0
– – – 3796
2022
Q4 		– Hold
0
– – – 3946
2022
Q3 		– Sell
-2
Closed -$7.87K – 4607
2022
Q2 		$5.1K Hold
2
– – ﹤0.01% 3821
2022
Q1 		$6.94K Sell
2
-3
-60% -$12.9K ﹤0.01% 3834
2021
Q4 		$33.7K Hold
5
– – ﹤0.01% 3804
2021
Q3 		$41.7K Buy
5
+4
+400% +$34.4K ﹤0.01% 3558
2021
Q2 		$7.71K Buy
+1
New +$16.4K ﹤0.01% 3770
2014
Q3 		– Hold
0
– -$486 – 4311
2014
Q2 		– Hold
0
– – – 3592
2014
Q1 		– Hold
0
– – – 3051
2013
Q4 		– Hold
0
– – – 3921

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BNP Paribas Financial Markets's SEEL Position: Q3 2024 in Review

BNP Paribas Financial Markets held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4261.

BNP Paribas Financial Markets first reported a position in SEEL in Q2 2021 and has held it in 5 quarters since. The position peaked at $41.7K in Q3 2021. 15 funds tracked by Wall St. Rank hold SEEL as of Q3 2024.

  • BNP Paribas Financial Markets held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q3 2024.
  • BNP Paribas Financial Markets left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q3 2024.
  • Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q3 2024, its #4261 holding.
  • BNP Paribas Financial Markets first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and has held it in 5 quarters since.
  • BNP Paribas Financial Markets's Seelos Therapeutics, Inc. Common Stock position peaked at $41.7K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.